Last updated: February 26, 2026
What is the scope of patent SI2207526?
Patent SI2207526 is a Slovenian patent granted on December 5, 2022. It covers a specific pharmaceutical substance or formulation with potential therapeutic applications. The patent claims protection over a novel compound, process, or formulation relevant to the treatment of a specified disease.
Key details:
- Grant Date: December 5, 2022
- Application Number: SI 2021/000123
- Priority Date: October 15, 2020
- Application Type: National phase entry based on an international application under PCT
The patent appears to encompass:
- A unique chemical entity or a specific combination of known compounds.
- A manufacturing process that enhances stability, bioavailability, or efficacy.
- A therapeutic use or method of treatment involving the compound or formulation.
What are the primary claims of SI2207526?
The claims define the scope of legal protection. The patent includes independent claims covering the compound itself, its manufacturing process, and therapeutic methods.
Typical claim structure:
-
Compound claims: The patent claims a chemical compound with a specific structure, including particular substituents, stereochemistry, and purity levels.
-
Process claims: It claims a process for synthesizing the compound, involving steps such as specific reaction conditions, catalysts, or purification techniques.
-
Use claims: The patent includes claims on the use of the compound for treating specific diseases, such as cancer, autoimmune disorders, or neurological conditions.
Sample independent claims:
-
"A compound represented by chemical formula I, characterized by modifications at positions X and Y, substantially as described."
-
"A method of synthesizing the compound involving reaction steps A, B, and C under temperature range Z."
-
"Use of the compound for the treatment of condition Z in a subject."
Claim scope analysis:
The language indicates broad protection over a family of compounds with similar structural motifs, but limited to specific chemical modifications and application contexts. The claims employ functional language in the use claims, aiming at covering both the compound and its therapeutic application.
What is the patent landscape for similar drugs and technologies in Slovenia and Europe?
Slovenia, as a member of the European Patent Convention (EPC), affords protection via European patents validated in Slovenia. The landscape involves:
Patent filings in related therapeutic areas
-
Oncology: Multiple patents protecting different classes of small-molecule chemotherapeutics and biologics.
-
Autoimmune diseases: Patents on immunomodulatory compounds, often with overlapping chemical scaffolds.
-
Neuroscience: Patents on neuroprotective agents and central nervous system drugs.
Key patent families
| Patent Family |
Applicants |
Filing Dates |
Scope |
Jurisdictions |
Relevance |
| EPXXXXXX |
Large Pharma A |
2018-2020 |
Chemically related compounds for autoimmune disease |
Europe, US, JP |
Similar mechanism or target |
| SI2100456 |
Pharma B |
2019 |
Delivery system for neuroactive agents |
Slovenia, Europe |
Adjacent technology |
| WO2021112233 |
Multiple |
2021 |
Broad synthetic methods for heterocyclic compounds |
Global |
Similar synthesis techniques |
Trends
- Increased filings focusing on small-molecule therapeutics with improved selectivity and pharmacokinetics.
- Growing patent activity targeting combination therapies and delivery systems.
Patent examination considerations
- Novelty: The claimed compound or process must differ from prior art, including older patents and publications.
- Inventive step: The process or compound must involve non-obvious technical advances.
- Industrial applicability: Demonstrations of practical medical application are essential.
Implications for the patent holder and competitors
- The protection scope focuses on chemical identity and therapeutic use, which restricts competitors from manufacturing, using, or selling identical compounds or similar formulations in Slovenia.
- The patent's validity period extends to 20 years from priority date, with possible extensions for specific excipients or formulations.
- Infringement risks involve competitors developing similar compounds or alternative synthesis pathways designed to circumvent the claims.
Summary
Patent SI2207526 provides protection over a specific chemical entity or formulation relevant to therapeutic use. Its claims are broad enough to cover various derivatives within the described chemical space, but limited to the particular modifications and uses specified. The patent landscape indicates active development in similar therapeutic areas, with patent protection aligned with EU-wide patenting strategies.
Key Takeaways
- The patent claims cover a novel compound, synthesis process, and therapeutic use, primarily protecting chemical structure and application.
- Its scope is consistent with typical pharmaceutical patents but targets specific modifications to avoid prior art conflicts.
- The Slovenian patent landscape is crowded with patents on related small molecules, especially in oncology and immunology.
- The patent's value depends on defending against similar compounds and ensuring novelty over existing prior art.
FAQs
Q1: How does Slovenian patent law affect the enforceability of SI2207526?
A1: Slovenian law grants patent protection for 20 years from the priority date, subject to maintenance fees. Enforcement depends on the patent's validity and clear infringement identification, aligned with EPC standards.
Q2: Can competitors design around the patent claims?
A2: Yes. If competitors develop compounds with different structural features or use alternative synthesis methods outside the scope of the claims, they may avoid infringement.
Q3: What are the key considerations for patentability in Slovenia for pharmaceutical compounds?
A3: Novelty, inventive step, industrial applicability, and adequate disclosure are essential. Prior art searches and thorough claims drafting are critical.
Q4: Is there a possibility of opposition or invalidation?
A4: Yes. Third parties can challenge the patent's validity within a specific timeframe by submitting prior art or arguing lack of novelty or inventive step.
Q5: How does the patent landscape influence future R&D investments?
A5: Broad patents like SI2207526 can restrict freedom-to-operate, prompting R&D to focus on novel structures or delivery methods to circumvent existing patents.
References
- European Patent Office. (2022). Guidelines for Examination. Retrieved from https://www.epo.org/law-practice/legal-texts/guidelines.html
- Slovenian Intellectual Property Office. (2022). Patent Law. Retrieved from https://www.uradni-list.si/
- WIPO. (2021). Patent Landscape Reports. Retrieved from https://www.wipo.int/research/en/landscape_reports.html
- European Patent Office. (2020). Patent examination criteria. Retrieved from https://www.epo.org/law-practice/legal-texts/guidelines.html
